{"transactions":[{"id":4624838,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":4503,"price":34.7,"value":156254.1,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options were granted on March 3, 2017, with 1,125 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 1,128 vested on March 3, 2021."}],"balance_after":0,"derivative":{"exercise_price":34.7,"expiration_date":"2027-03-03","underlying":"Ordinary Shares","underlying_shares":4503},"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624837,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":314,"price":38.7038,"value":12152.9932,"ownership":{"direct":true},"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624836,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":2525,"price":39.145,"value":98841.125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.14 to $39.155, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":8814,"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624835,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":4503,"price":38.69,"value":174221.07,"ownership":{"direct":true},"balance_after":11339,"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624834,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-22T21:01:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":4503,"price":34.7,"value":156254.1,"ownership":{"direct":true},"balance_after":15842,"source":{"system":"sec-edgar","filing":"0001193125-26-398105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2112339/000119312526398105/ownership.xml","form_type":"4"}},{"id":4624656,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-22T20:21:45.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":367600,"price":39.0555,"value":14356801.8,"ownership":{"direct":false,"nature":"[see footnote]"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.68 to $39.38, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The 367,600 Ordinary Shares disclosed in Table I of this Form 4 were held of record by Swiftcurrent Master Fund Ltd. (the \"Fund\"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone was deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaimed beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone was the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-397959","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258394/000119312526397959/ownership.xml","form_type":"4"}},{"id":676738,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20121,"kind":"person","name":"Weiss Amir","position":1,"cik":"0001897057","reported_name":"Weiss Amir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Options (right to buy)","published_at":"2026-08-25T20:05:09.000Z","date":"2026-08-21","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":19.16,"value":47900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock options were granted on March 3, 2018, with 2,500 having vested on each of March 2, 2019, March 2, 2020 and March 2, 2021 and 2,502 having vested on March 2, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7502,"derivative":{"exercise_price":19.16,"expiration_date":"2028-03-02","underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001193125-26-365116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526365116/ownership.xml","form_type":"4"}},{"id":676737,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20121,"kind":"person","name":"Weiss Amir","position":1,"cik":"0001897057","reported_name":"Weiss Amir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-25T20:05:09.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":37.6307,"value":94076.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":13071,"source":{"system":"sec-edgar","filing":"0001193125-26-365116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526365116/ownership.xml","form_type":"4"}},{"id":676736,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20121,"kind":"person","name":"Weiss Amir","position":1,"cik":"0001897057","reported_name":"Weiss Amir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-25T20:05:09.000Z","date":"2026-08-21","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":19.61,"value":49025.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":15571,"source":{"system":"sec-edgar","filing":"0001193125-26-365116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526365116/ownership.xml","form_type":"4"}},{"id":676735,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20121,"kind":"person","name":"Weiss Amir","position":1,"cik":"0001897057","reported_name":"Weiss Amir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-25T20:05:09.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":6945,"price":37.6133,"value":261224.3685,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.61 to $31.62, inclusive. The reporting person undertakes to provide, upon request by the SEC staff,\nthe issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":13071,"source":{"system":"sec-edgar","filing":"0001193125-26-365116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526365116/ownership.xml","form_type":"4"}},{"id":676734,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20120,"kind":"person","name":"Satchi-Fainaro Ronit","position":1,"cik":"0001742782","reported_name":"Satchi-Fainaro Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-25T20:03:12.000Z","date":"2026-08-21","kind":"sale","planned":false,"acquired":false,"shares":415,"price":37.25,"value":15458.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":111986,"source":{"system":"sec-edgar","filing":"0001193125-26-365107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526365107/ownership.xml","form_type":"4"}},{"id":682186,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":21884,"kind":"person","name":"Lippman Evan","position":1,"cik":"0002062834","reported_name":"Lippman Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Ordinary Shares","published_at":"2026-08-19T20:00:53.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":18600,"price":36.5748,"value":680291.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $36.61, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":25591,"source":{"system":"sec-edgar","filing":"0001193125-26-356853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526356853/ownership.xml","form_type":"4"}},{"id":692501,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-10T10:07:40.000Z","date":"2026-08-05","kind":"sale","planned":false,"acquired":false,"shares":17,"price":34.8655,"value":592.7135,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":73247,"source":{"system":"sec-edgar","filing":"0001193125-26-341086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526341086/ownership.xml","form_type":"4"}},{"id":696388,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-08-05T20:04:34.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":12827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on August 1, 2024, with 12,827 vested on each of August 1, 2025 and August 1, 2026, 12,827 vesting on August 1, 2027, and 12,830 vesting on August 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on August 1, 2024, with 12,827 vested on each of August 1, 2025 and August 1, 2026, 12,827 vesting on August 1, 2027, and 12,830 vesting on August 1, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":25657,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12827},"source":{"system":"sec-edgar","filing":"0001193125-26-335026","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335026/ownership.xml","form_type":"4"}},{"id":696387,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:04:34.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":12827,"price":34.8757,"value":447350.6039,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.66 to $35.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6774,"source":{"system":"sec-edgar","filing":"0001193125-26-335026","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335026/ownership.xml","form_type":"4"}},{"id":696386,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:04:34.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":12827,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":19601,"source":{"system":"sec-edgar","filing":"0001193125-26-335026","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335026/ownership.xml","form_type":"4"}},{"id":696385,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-08-05T20:02:30.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":52744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vested on August 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vested on August 1, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":52744},"source":{"system":"sec-edgar","filing":"0001193125-26-335012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335012/ownership.xml","form_type":"4"}},{"id":696384,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:02:30.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":25578,"price":34.8757,"value":892050.6546,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.66 to $35.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":134877,"source":{"system":"sec-edgar","filing":"0001193125-26-335012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335012/ownership.xml","form_type":"4"}},{"id":696383,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:02:30.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":52744,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":160455,"source":{"system":"sec-edgar","filing":"0001193125-26-335012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335012/ownership.xml","form_type":"4"}},{"id":731254,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":36564,"kind":"person","name":"Shields Matthew","position":1,"cik":"0002025621","reported_name":"Shields Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Operations"}}],"security":"Ordinary Shares","published_at":"2026-06-22T20:00:55.000Z","date":"2026-06-18","kind":"sale","planned":false,"acquired":false,"shares":9989,"price":32.1901,"value":321546.9089,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-277490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526277490/ownership.xml","form_type":"4"}},{"id":737016,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37892,"kind":"person","name":"Kalif Eliyahu Sharon","position":1,"cik":"0001798443","reported_name":"Kalif Eliyahu Sharon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-16T12:28:00.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":106563,"price":34.0954,"value":3633308.1102,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.985 to $34.25, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":65621,"source":{"system":"sec-edgar","filing":"0001193125-26-271862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526271862/ownership.xml","form_type":"4"}},{"id":747063,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:07:08.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":21739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":21739},"source":{"system":"sec-edgar","filing":"0001193125-26-261715","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261715/ownership.xml","form_type":"4"}},{"id":747062,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:07:08.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":21739,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":448011,"source":{"system":"sec-edgar","filing":"0001193125-26-261715","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261715/ownership.xml","form_type":"4"}},{"id":747061,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":33051,"kind":"person","name":"Lichtenstein Chen","position":1,"cik":"0002046465","reported_name":"Lichtenstein Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:06:39.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261712/ownership.xml","form_type":"4"}},{"id":747060,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":33051,"kind":"person","name":"Lichtenstein Chen","position":1,"cik":"0002046465","reported_name":"Lichtenstein Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:06:39.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":19296,"source":{"system":"sec-edgar","filing":"0001193125-26-261712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261712/ownership.xml","form_type":"4"}},{"id":747059,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40718,"kind":"person","name":"Crane Rosemary A","position":1,"cik":"0001443343","reported_name":"Crane Rosemary A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:06:11.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261706","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261706/ownership.xml","form_type":"4"}},{"id":747058,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40718,"kind":"person","name":"Crane Rosemary A","position":1,"cik":"0001443343","reported_name":"Crane Rosemary A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:06:11.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":127739,"source":{"system":"sec-edgar","filing":"0001193125-26-261706","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261706/ownership.xml","form_type":"4"}},{"id":747057,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":32350,"kind":"person","name":"Elstein Amir","position":1,"cik":"0001721354","reported_name":"Elstein Amir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:05:14.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261701","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261701/ownership.xml","form_type":"4"}},{"id":747056,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":32350,"kind":"person","name":"Elstein Amir","position":1,"cik":"0001721354","reported_name":"Elstein Amir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:05:14.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":2118455,"source":{"system":"sec-edgar","filing":"0001193125-26-261701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261701/ownership.xml","form_type":"4"}},{"id":747055,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:04:59.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261691/ownership.xml","form_type":"4"}},{"id":747054,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:04:59.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":130149,"source":{"system":"sec-edgar","filing":"0001193125-26-261691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261691/ownership.xml","form_type":"4"}},{"id":747053,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40716,"kind":"person","name":"Nisen Perry","position":1,"cik":"0001683791","reported_name":"Nisen Perry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:04:32.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261688/ownership.xml","form_type":"4"}},{"id":747052,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40716,"kind":"person","name":"Nisen Perry","position":1,"cik":"0001683791","reported_name":"Nisen Perry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:04:32.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":119807,"source":{"system":"sec-edgar","filing":"0001193125-26-261688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261688/ownership.xml","form_type":"4"}},{"id":747051,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20120,"kind":"person","name":"Satchi-Fainaro Ronit","position":1,"cik":"0001742782","reported_name":"Satchi-Fainaro Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:03:21.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261677","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261677/ownership.xml","form_type":"4"}},{"id":747050,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20120,"kind":"person","name":"Satchi-Fainaro Ronit","position":1,"cik":"0001742782","reported_name":"Satchi-Fainaro Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:03:21.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":112401,"source":{"system":"sec-edgar","filing":"0001193125-26-261677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261677/ownership.xml","form_type":"4"}},{"id":747049,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:03:06.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261676","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261676/ownership.xml","form_type":"4"}},{"id":747048,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:03:06.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":73264,"source":{"system":"sec-edgar","filing":"0001193125-26-261676","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261676/ownership.xml","form_type":"4"}},{"id":747047,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:02:38.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":14492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on June 5, 2025 and vested on June 5, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14492},"source":{"system":"sec-edgar","filing":"0001193125-26-261672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261672/ownership.xml","form_type":"4"}},{"id":747046,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:02:38.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":14492,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":119807,"source":{"system":"sec-edgar","filing":"0001193125-26-261672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261672/ownership.xml","form_type":"4"}},{"id":747045,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:01:07.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":false,"shares":13043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on June 5, 2025, with 13,043 vested on June 5, 2026, 13,043 vesting on each of June 5, 2027 and June 5, 2028, and 13,044 vesting on June 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on June 5, 2025, with 13,043 vested on June 5, 2026, 13,043 vesting on each of June 5, 2027 and June 5, 2028, and 13,044 vesting on June 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":39130,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13043},"source":{"system":"sec-edgar","filing":"0001193125-26-261660","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261660/ownership.xml","form_type":"4"}},{"id":747044,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:01:07.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":6153,"price":34.35,"value":211355.55,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."}],"balance_after":1177529,"source":{"system":"sec-edgar","filing":"0001193125-26-261660","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261660/ownership.xml","form_type":"4"}},{"id":747043,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:01:07.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":true,"shares":13043,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1183682,"source":{"system":"sec-edgar","filing":"0001193125-26-261660","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261660/ownership.xml","form_type":"4"}},{"id":750301,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":36564,"kind":"person","name":"Shields Matthew","position":1,"cik":"0002025621","reported_name":"Shields Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Share Units","published_at":"2026-06-04T20:00:49.000Z","date":"2026-06-03","kind":"exercise","planned":true,"acquired":false,"shares":16195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on June 3, 2024, with 16,195 vested on each of June 3, 2025 and June 3, 2026, 16,195 vesting on June 3, 2027, and 16,197 vesting on June 3, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on June 3, 2024, with 16,195 vested on each of June 3, 2025 and June 3, 2026, 16,195 vesting on June 3, 2027, and 16,197 vesting on June 3, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":32392,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16195},"source":{"system":"sec-edgar","filing":"0001193125-26-257344","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526257344/ownership.xml","form_type":"4"}},{"id":750300,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":36564,"kind":"person","name":"Shields Matthew","position":1,"cik":"0002025621","reported_name":"Shields Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Operations"}}],"security":"Ordinary Shares","published_at":"2026-06-04T20:00:49.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":16195,"price":32.87,"value":532329.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."}],"balance_after":9989,"source":{"system":"sec-edgar","filing":"0001193125-26-257344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526257344/ownership.xml","form_type":"4"}},{"id":750299,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":36564,"kind":"person","name":"Shields Matthew","position":1,"cik":"0002025621","reported_name":"Shields Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Operations"}}],"security":"Ordinary Shares","published_at":"2026-06-04T20:00:49.000Z","date":"2026-06-03","kind":"exercise","planned":true,"acquired":true,"shares":16195,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":26184,"source":{"system":"sec-edgar","filing":"0001193125-26-257344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526257344/ownership.xml","form_type":"4"}},{"id":757995,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":25234,"kind":"person","name":"Zaks Tal Zvi","position":1,"cik":"0001690927","reported_name":"Zaks Tal Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:16:53.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251459/ownership.xml","form_type":"4"}},{"id":757994,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20120,"kind":"person","name":"Satchi-Fainaro Ronit","position":1,"cik":"0001742782","reported_name":"Satchi-Fainaro Ronit","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:15:03.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251452","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251452/ownership.xml","form_type":"4"}},{"id":757993,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40716,"kind":"person","name":"Nisen Perry","position":1,"cik":"0001683791","reported_name":"Nisen Perry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:13:45.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251441","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251441/ownership.xml","form_type":"4"}},{"id":757992,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40717,"kind":"person","name":"LIEBERMAN GERALD M","position":1,"cik":"0001234346","reported_name":"LIEBERMAN GERALD M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:11:33.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251434/ownership.xml","form_type":"4"}},{"id":757991,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":32350,"kind":"person","name":"Elstein Amir","position":1,"cik":"0001721354","reported_name":"Elstein Amir","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:09:58.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251423/ownership.xml","form_type":"4"}},{"id":757990,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40718,"kind":"person","name":"Crane Rosemary A","position":1,"cik":"0001443343","reported_name":"Crane Rosemary A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:08:27.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251416/ownership.xml","form_type":"4"}},{"id":757989,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":33051,"kind":"person","name":"Lichtenstein Chen","position":1,"cik":"0002046465","reported_name":"Lichtenstein Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:06:34.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251405","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251405/ownership.xml","form_type":"4"}},{"id":757988,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40719,"kind":"person","name":"BARER SOL J","position":1,"cik":"0001247015","reported_name":"BARER SOL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:03:55.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":10863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":10863,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10863},"source":{"system":"sec-edgar","filing":"0001193125-26-251384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251384/ownership.xml","form_type":"4"}},{"id":757986,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20298,"kind":"person","name":"MIGNONE ROBERTO","position":1,"cik":"0001258394","reported_name":"MIGNONE ROBERTO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-01T20:02:23.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":7242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on May 28, 2026 and vest on May 28, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":7242,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7242},"source":{"system":"sec-edgar","filing":"0001193125-26-251372","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526251372/ownership.xml","form_type":"4"}},{"id":776057,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":21884,"kind":"person","name":"Lippman Evan","position":1,"cik":"0002062834","reported_name":"Lippman Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Restricted Share Units","published_at":"2026-05-18T20:02:42.000Z","date":"2026-05-14","kind":"exercise","planned":true,"acquired":false,"shares":74008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on May 14, 2025, with 74,008 vested on May 14, 2026, and 37,004 vesting on each of May 14, 2027 and May 14, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on May 14, 2025, with 74,008 vested on May 14, 2026, and 37,004 vesting on each of May 14, 2027 and May 14, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":74008,"derivative":{"underlying":"Ordinary Shares","underlying_shares":74008},"source":{"system":"sec-edgar","filing":"0001193125-26-228876","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526228876/ownership.xml","form_type":"4"}},{"id":776056,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":21884,"kind":"person","name":"Lippman Evan","position":1,"cik":"0002062834","reported_name":"Lippman Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Restricted Share Units","published_at":"2026-05-18T20:02:42.000Z","date":"2026-05-14","kind":"exercise","planned":true,"acquired":false,"shares":11841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on May 14, 2025, with 11,841 vested on May 14, 2026, 11,841 vesting on each of May 14, 2027 and May 14, 2028, and 11,842 vesting on May 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on May 14, 2025, with 11,841 vested on May 14, 2026, 11,841 vesting on each of May 14, 2027 and May 14, 2028, and 11,842 vesting on May 14, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":35524,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11841},"source":{"system":"sec-edgar","filing":"0001193125-26-228876","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526228876/ownership.xml","form_type":"4"}},{"id":776055,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":21884,"kind":"person","name":"Lippman Evan","position":1,"cik":"0002062834","reported_name":"Lippman Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Ordinary Shares","published_at":"2026-05-18T20:02:42.000Z","date":"2026-05-14","kind":"sale","planned":true,"acquired":false,"shares":35912,"price":35.5842,"value":1277899.7904,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.38 to $35.685, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":44191,"source":{"system":"sec-edgar","filing":"0001193125-26-228876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526228876/ownership.xml","form_type":"4"}},{"id":776054,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":21884,"kind":"person","name":"Lippman Evan","position":1,"cik":"0002062834","reported_name":"Lippman Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Ordinary Shares","published_at":"2026-05-18T20:02:42.000Z","date":"2026-05-14","kind":"exercise","planned":true,"acquired":true,"shares":74008,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":80103,"source":{"system":"sec-edgar","filing":"0001193125-26-228876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526228876/ownership.xml","form_type":"4"}},{"id":776053,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":21884,"kind":"person","name":"Lippman Evan","position":1,"cik":"0002062834","reported_name":"Lippman Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Ordinary Shares","published_at":"2026-05-18T20:02:42.000Z","date":"2026-05-14","kind":"sale","planned":true,"acquired":false,"shares":5746,"price":35.5842,"value":204466.8132,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.38 to $35.685, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6095,"source":{"system":"sec-edgar","filing":"0001193125-26-228876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526228876/ownership.xml","form_type":"4"}},{"id":776052,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":21884,"kind":"person","name":"Lippman Evan","position":1,"cik":"0002062834","reported_name":"Lippman Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Business Development"}}],"security":"Ordinary Shares","published_at":"2026-05-18T20:02:42.000Z","date":"2026-05-14","kind":"exercise","planned":true,"acquired":true,"shares":11841,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":11841,"source":{"system":"sec-edgar","filing":"0001193125-26-228876","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526228876/ownership.xml","form_type":"4"}},{"id":776051,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37892,"kind":"person","name":"Kalif Eliyahu Sharon","position":1,"cik":"0001798443","reported_name":"Kalif Eliyahu Sharon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-18T20:00:48.000Z","date":"2026-05-14","kind":"sale","planned":true,"acquired":false,"shares":153251,"price":35.6107,"value":5457375.3857,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.59 to $35.80, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":172184,"source":{"system":"sec-edgar","filing":"0001193125-26-228870","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526228870/ownership.xml","form_type":"4"}},{"id":789136,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20121,"kind":"person","name":"Weiss Amir","position":1,"cik":"0001897057","reported_name":"Weiss Amir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-07T20:03:44.000Z","date":"2026-05-06","kind":"sale","planned":false,"acquired":false,"shares":10679,"price":36,"value":384444.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":20016,"source":{"system":"sec-edgar","filing":"0001193125-26-211855","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526211855/ownership.xml","form_type":"4"}},{"id":789135,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-05-07T20:01:55.000Z","date":"2026-05-05","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":35.4,"value":1062000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":55755,"source":{"system":"sec-edgar","filing":"0001193125-26-211833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526211833/ownership.xml","form_type":"4"}},{"id":794642,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50096,"kind":"person","name":"Sabag Mark","position":1,"cik":"0001721442","reported_name":"Sabag Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-05-04T20:02:22.000Z","date":"2026-05-01","kind":"sale","planned":false,"acquired":false,"shares":144180,"price":34.9918,"value":5045117.724,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.935 to $35.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":80760,"source":{"system":"sec-edgar","filing":"0001193125-26-203928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526203928/ownership.xml","form_type":"4"}},{"id":794641,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2026-05-04T20:00:53.000Z","date":"2026-04-30","kind":"sale","planned":false,"acquired":false,"shares":21258,"price":35.31,"value":750619.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.28 to $35.33, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":63647,"source":{"system":"sec-edgar","filing":"0001193125-26-203920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526203920/ownership.xml","form_type":"4"}},{"id":834121,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50096,"kind":"person","name":"Sabag Mark","position":1,"cik":"0001721442","reported_name":"Sabag Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-19T20:01:11.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":62102,"price":30.141,"value":1871816.382,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.115 to $30.215, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":224940,"source":{"system":"sec-edgar","filing":"0001193125-26-115929","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526115929/ownership.xml","form_type":"4"}},{"id":854931,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50096,"kind":"person","name":"Sabag Mark","position":1,"cik":"0001721442","reported_name":"Sabag Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:23:23.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":15723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 5, 2025, with 15,723 vested on March 5, 2026, 15,723 vesting on each of March 5, 2027 and March 5, 2028, and 15,724 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 5, 2025, with 15,723 vested on March 5, 2026, 15,723 vesting on each of March 5, 2027 and March 5, 2028, and 15,724 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":47170,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15723},"source":{"system":"sec-edgar","filing":"0001193125-26-098582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098582/ownership.xml","form_type":"4"}},{"id":854930,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50096,"kind":"person","name":"Sabag Mark","position":1,"cik":"0001721442","reported_name":"Sabag Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:23:23.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":15723,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":287042,"source":{"system":"sec-edgar","filing":"0001193125-26-098582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098582/ownership.xml","form_type":"4"}},{"id":854929,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37892,"kind":"person","name":"Kalif Eliyahu Sharon","position":1,"cik":"0001798443","reported_name":"Kalif Eliyahu Sharon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:22:06.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":19916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 5, 2025, with 19,916 vested on March 5, 2026, and 19,916 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 5, 2025, with 19,916 vested on March 5, 2026, and 19,916 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":59748,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19916},"source":{"system":"sec-edgar","filing":"0001193125-26-098573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098573/ownership.xml","form_type":"4"}},{"id":854928,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":37892,"kind":"person","name":"Kalif Eliyahu Sharon","position":1,"cik":"0001798443","reported_name":"Kalif Eliyahu Sharon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:22:06.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":19916,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":325435,"source":{"system":"sec-edgar","filing":"0001193125-26-098573","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098573/ownership.xml","form_type":"4"}},{"id":854927,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20121,"kind":"person","name":"Weiss Amir","position":1,"cik":"0001897057","reported_name":"Weiss Amir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:19:34.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":3537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 5, 2025, with 3,537 vested on March 5, 2026, 3,537 vesting on each of March 5, 2027 and March 5, 2028, and 3,539 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 5, 2025, with 3,537 vested on March 5, 2026, 3,537 vesting on each of March 5, 2027 and March 5, 2028, and 3,539 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":10613,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3537},"source":{"system":"sec-edgar","filing":"0001193125-26-098560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098560/ownership.xml","form_type":"4"}},{"id":854926,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":20121,"kind":"person","name":"Weiss Amir","position":1,"cik":"0001897057","reported_name":"Weiss Amir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:19:34.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":3537,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":30695,"source":{"system":"sec-edgar","filing":"0001193125-26-098560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098560/ownership.xml","form_type":"4"}},{"id":854925,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:18:05.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":42452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 42,452 vested on March 5, 2026, 42,452 vesting on each of March 5, 2027 and March 5, 2028, and 42,455 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 42,452 vested on March 5, 2026, 42,452 vesting on each of March 5, 2027 and March 5, 2028, and 42,455 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":127359,"derivative":{"underlying":"Ordinary Shares","underlying_shares":42452},"source":{"system":"sec-edgar","filing":"0001193125-26-098551","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098551/ownership.xml","form_type":"4"}},{"id":854924,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:18:05.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":20025,"price":31.6684,"value":634159.71,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1170639,"source":{"system":"sec-edgar","filing":"0001193125-26-098551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098551/ownership.xml","form_type":"4"}},{"id":854923,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:18:05.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":42452,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1190664,"source":{"system":"sec-edgar","filing":"0001193125-26-098551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098551/ownership.xml","form_type":"4"}},{"id":854922,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:16:34.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":17819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,819 vested on March 5, 2026, 17,819 vesting on each of March 5, 2027 and March 5, 2028, and 17,821 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,819 vested on March 5, 2026, 17,819 vesting on each of March 5, 2027 and March 5, 2028, and 17,821 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":53459,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17819},"source":{"system":"sec-edgar","filing":"0001193125-26-098541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098541/ownership.xml","form_type":"4"}},{"id":854921,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:16:34.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":7924,"price":31.6684,"value":250940.4016,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":84905,"source":{"system":"sec-edgar","filing":"0001193125-26-098541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098541/ownership.xml","form_type":"4"}},{"id":854920,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":50095,"kind":"person","name":"Fox Christine","position":1,"cik":"0001998173","reported_name":"Fox Christine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, U.S. Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:16:34.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":17819,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":92829,"source":{"system":"sec-edgar","filing":"0001193125-26-098541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098541/ownership.xml","form_type":"4"}},{"id":854919,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:14:56.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":19654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 19,654 vested on March 5, 2026, and 19,654 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 19,654 vested on March 5, 2026, and 19,654 vesting on each of March 5, 2027, March 5, 2028 and March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":58962,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19654},"source":{"system":"sec-edgar","filing":"0001193125-26-098524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098524/ownership.xml","form_type":"4"}},{"id":854918,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:14:56.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":9533,"price":31.6684,"value":301894.8572,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":107711,"source":{"system":"sec-edgar","filing":"0001193125-26-098524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098524/ownership.xml","form_type":"4"}},{"id":854917,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26426,"kind":"person","name":"Hughes Eric A","position":1,"cik":"0001938678","reported_name":"Hughes Eric A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:14:56.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":19654,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":117244,"source":{"system":"sec-edgar","filing":"0001193125-26-098524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098524/ownership.xml","form_type":"4"}},{"id":854916,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:12:26.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":17295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,295 vested on March 5, 2026, 17,295 vesting on each of March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,295 vested on March 5, 2026, 17,295 vesting on each of March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":51887,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17295},"source":{"system":"sec-edgar","filing":"0001193125-26-098512","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098512/ownership.xml","form_type":"4"}},{"id":854915,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:12:26.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":17295,"price":31.6684,"value":547704.978,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":85755,"source":{"system":"sec-edgar","filing":"0001193125-26-098512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098512/ownership.xml","form_type":"4"}},{"id":854914,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:12:26.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":17295,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":103050,"source":{"system":"sec-edgar","filing":"0001193125-26-098512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098512/ownership.xml","form_type":"4"}},{"id":854913,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:10:30.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":42453,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001193125-26-098506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098506/ownership.xml","form_type":"4"}},{"id":854912,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:10:30.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":14150,"price":31.6684,"value":448107.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6774,"source":{"system":"sec-edgar","filing":"0001193125-26-098506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098506/ownership.xml","form_type":"4"}},{"id":854911,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:10:30.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":14150,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":20924,"source":{"system":"sec-edgar","filing":"0001193125-26-098506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098506/ownership.xml","form_type":"4"}},{"id":854910,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:09:13.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":3580,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 5, 2025, with 3,580 vested on March 5, 2026, and 3,580 vesting on each of March 5, 2027, March 7, 2028 and March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 5, 2025, with 3,580 vested on March 5, 2026, and 3,580 vesting on each of March 5, 2027, March 7, 2028 and March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":10740,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3580},"source":{"system":"sec-edgar","filing":"0001193125-26-098501","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098501/ownership.xml","form_type":"4"}},{"id":854909,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:09:13.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":1127,"price":31.6684,"value":35690.2868,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10914,"source":{"system":"sec-edgar","filing":"0001193125-26-098501","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098501/ownership.xml","form_type":"4"}},{"id":854908,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":62164,"kind":"person","name":"Savage Brian","position":1,"cik":"0002112339","reported_name":"Savage Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:09:13.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":3580,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":12041,"source":{"system":"sec-edgar","filing":"0001193125-26-098501","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098501/ownership.xml","form_type":"4"}},{"id":854907,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":36564,"kind":"person","name":"Shields Matthew","position":1,"cik":"0002025621","reported_name":"Shields Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Operations"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:05:39.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":17295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,295 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 17,295 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":51887,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17295},"source":{"system":"sec-edgar","filing":"0001193125-26-098473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098473/ownership.xml","form_type":"4"}},{"id":854906,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":36564,"kind":"person","name":"Shields Matthew","position":1,"cik":"0002025621","reported_name":"Shields Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Operations"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:05:39.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":17295,"price":31.6684,"value":547704.978,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":9989,"source":{"system":"sec-edgar","filing":"0001193125-26-098473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098473/ownership.xml","form_type":"4"}},{"id":854905,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":36564,"kind":"person","name":"Shields Matthew","position":1,"cik":"0002025621","reported_name":"Shields Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Operations"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:05:39.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":17295,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":27284,"source":{"system":"sec-edgar","filing":"0001193125-26-098473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098473/ownership.xml","form_type":"4"}},{"id":857169,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:19:36.000Z","date":"2026-03-04","kind":"grant","planned":true,"acquired":true,"shares":136736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 34,184 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 34,184 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":136736,"derivative":{"underlying":"Ordinary Shares","underlying_shares":136736},"source":{"system":"sec-edgar","filing":"0001193125-26-096591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096591/ownership.xml","form_type":"4"}},{"id":857168,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:19:36.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":50223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 50,223 vested on each of March 4, 2025 and March 4, 2026, and 50,223 vesting on each of March 4, 2027 and March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 50,223 vested on each of March 4, 2025 and March 4, 2026, and 50,223 vesting on each of March 4, 2027 and March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":100446,"derivative":{"underlying":"Ordinary Shares","underlying_shares":50223},"source":{"system":"sec-edgar","filing":"0001193125-26-096591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096591/ownership.xml","form_type":"4"}},{"id":857167,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:19:36.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":23393,"price":32.4645,"value":759442.0485,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.095 to $33.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1148212,"source":{"system":"sec-edgar","filing":"0001193125-26-096591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096591/ownership.xml","form_type":"4"}},{"id":857166,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:19:36.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":50223,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1171605,"source":{"system":"sec-edgar","filing":"0001193125-26-096591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096591/ownership.xml","form_type":"4"}},{"id":857165,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"grant","planned":true,"acquired":true,"shares":33424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Restricted share units were granted on March 4, 2026, with 8,356 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Restricted share units were granted on March 4, 2026, with 8,356 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":33424,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33424},"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857164,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":20461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on each of March 4, 2025 and March 4, 2026, 20,461 vesting on March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on March 4, 2024, with 20,461 vested on each of March 4, 2025 and March 4, 2026, 20,461 vesting on March 4, 2027, and 20,462 vesting on March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":40923,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20461},"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}},{"id":857163,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":49247,"kind":"person","name":"Daniell Richard","position":1,"cik":"0001726096","reported_name":"Daniell Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Europe Commercial"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:17:54.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":33512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33512},"source":{"system":"sec-edgar","filing":"0001193125-26-096584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096584/ownership.xml","form_type":"4"}}],"next_cursor":"2026-03-06T21:17:54.000000Z,857163"}